The British Emergex development is a small pillow that, when placed on the skin, begins to work and tries to kill infected cells. Maybe this will be the most practical solution against COVID?
Success has crowned British Emergex’s “patchy” COVID vaccine to date, allowing the company to begin clinical trials of the product, The Guardian reported Hvg.hu.
Emergex did not produce a traditional vaccine, but a pillow-like device that attaches to the skin with the small hooks it contains. According to the manufacturer, the medicine uses so-called T cells (‘heavy bombers’ in the immune system) to kill infected cells.
The researchers began developing the vaccine, citing a study published in the scientific journal Nature. Research mentions a so-called abortion infection, which is a mild disease with a shorter content. According to researchers the virus enters the body at this time, but the T cells in the immune system destroy it very quickly.
This discovery, scientists say, could pave the way for a new generation of vaccines that could achieve immunity for much longer periods of time, even decades.
For Emergex, the vaccine is contained in a thumb-sized skin patch; the microneedles on it deliver the medicine to the body. The operation, according to the company, takes a few seconds and is much more convenient. Another advantage of this technique is that the vaccine, unlike other vaccines, can be stored at room temperature for up to three months.
The permit required for the clinical trial was issued by the Swiss Medicines Authority, beginning on 3 January. The first results of the method are expected by experts next summer, but the Emergex patch will only be available around 2025 at the earliest.
It turns out – The effectiveness of vaccines against Covid is falling dramatically
Source: Napidoktor by napidoktor.hu.
*The article has been translated based on the content of Napidoktor by napidoktor.hu. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!